Inventor
WRIGHT DAVID ERICK
US8 patents
⚠️ This page may combine multiple inventors who share the name “WRIGHT DAVID ERICK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HORIZON THERAPEUTICS USA INC
5 patentsUS11639927B2May 2, 2023
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
HORIZON THERAPEUTICS USA INC7 citations84
US11598767B2Mar 7, 2023
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
HORIZON THERAPEUTICS USA INC5 citations84
US12560596B2Feb 24, 2026
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
HORIZON THERAPEUTICS USA INC0 citations61
US12188927B2Jan 7, 2025
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
HORIZON THERAPEUTICS USA INC0 citations61
US11982670B2May 14, 2024
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
HORIZON THERAPEUTICS USA INC0 citations61
HORIZON PHARMA RHEUMATOLOGY LLC
2 patentsUS10823727B2Nov 3, 2020
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
HORIZON PHARMA RHEUMATOLOGY LLC12 citations92
US10139399B2Nov 27, 2018
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
HORIZON PHARMA RHEUMATOLOGY LLC11 citations91